Scilex Holding CompanyCH Trading Group will serve as exclusive territories distributor in the Middle East and North Africa countries with US $105 million minimum purchase commitment. About Scilex Holding CompanyScilex Holding Company is an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. ZTlido® is a registered trademark owned by Scilex Pharmaceuticals Inc., a wholly-owned subsidiary of Scilex Holding Company. Gloperba® is an exclusive, transferable license to use the registered trademark by Scilex Holding Company. ELYXYB™ is an exclusive, transferable license to use the trademark by Scilex Holding Company.

Source: The North Africa Journal March 08, 2023 21:57 UTC